+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Acne Medication Market By Therapeutic Class, By Formulation, By Type, By Acne Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2024-2035

  • PDF Icon

    Report

  • 280 Pages
  • April 2024
  • Region: Global
  • Allied Market Research
  • ID: 6010514
Description Jump to:
The global acne medication market was valued at $13.4 billion in 2023, and is estimated to reach $24.2 billion by 2035, growing at a CAGR of 5.1% from 2024 to 2035. Acne is a common skin condition characterized by the formulation of pimples, blackheads, whiteheads, cysts, or nodules, usually appearing on the face, chest, back, or shoulders. It occurs when hair follicles become clogged with oil and dead skin cells, leading to the proliferation of bacteria and inflammation. Several factors contribute to the development of acne, including hormonal fluctuations, genetics, excess oil production, bacteria, and certain medications or cosmetics. The treatment includes retinoid, antibiotic, salicylic acid, benzoyl peroxide, and other medications.

The acne medication market is expected to register significant growth due to rise in incidences of acne and unhealthy diet. Acne is one of the most common skin conditions globally, affecting individuals of all ages, genders, and ethnicities. Its prevalence has been steadily increasing over the years, driven by factors such as hormonal changes, environmental influences, dietary habits, and lifestyle choices. According to a 2023 article by the National Library of Medicine, acne vulgaris is commonly observed in adolescents and young adults. Prevalence rate of acne vulgaris is estimated to range from 35% to over 90% among adolescents. Thus, rise in the prevalence of acne is expected to drive the growth of the market.Furthermore, an unhealthy lifestyle serves as a significant driver for the acne medication market. Lifestyle factors such as poor dietary habits, high stress levels, inadequate sleep, and exposure to environmental pollutants contribute to the development and exacerbation of acne. Unbalanced diets high in refined sugars, processed foods, and dairy products can trigger hormonal fluctuations and increase sebum production, both of which are key factors in acne formulation. In addition, elevated stress levels stimulate the release of stress hormones like cortisol, which can lead to inflammation and exacerbate existing acne lesions. According to a 2023 article by Anxiety and Depression Association of America, it was reported that Generalized Anxiety Disorder affects 6.8 million adults or 3.1% of the U.S. population. Furthermore, insufficient sleep disrupts the body's natural healing processes and weakens the immune system, making individuals more susceptible to bacterial infections and inflammation associated with acne. Thus, the unhealthy lifestyle has resulted in growing incidence of acne resulting in increase in demand for acne medication.The acne medication market is segmented on the basis of therapeutic class, formulation, type, acne type, distribution channel, and region. By therapeutic class, the market is divided into retinoid, antibiotic, salicylic acid, benzoyl peroxide, and others. By formulation, the market is classified into topical and oral medication. By type, the market is distributed into prescription medicine and over-the-counter medicines. By acne type, the market is distributed into non-inflammatory acne and inflammatory acne. By distribution channel, the market is classified into retail stores, pharmacy and drug stores, and e-commerce. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA)Major key players operating in the acne medication market are Bausch Health Companies Inc., Mayne Pharma Group Limited, Sun Pharmaceutical Industries Limited, Johnson and Johnson, GlaxoSmithKline Plc, Mylan N.V., Almirall Sa, Galderma S.A., Teva Pharmaceutical Industries Ltd., and Pfizer Inc. Key players have adopted acquisition as a key developmental strategy to improve the product portfolio of the acne medication market

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the acne medication market analysis from 2023 to 2035 to identify the prevailing acne medication market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the acne medication market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global acne medication market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Prescription Medicine
  • Over-the-counter medicines

By Therapeutic Class

  • Other medications
  • Retinoid
  • Type
  • Topical and Combination retinoid
  • Oral Retinoid
  • Antibiotic
  • Type
  • Topical and Combination Antibiotics
  • Oral Antibiotics
  • Salicylic Acid
  • Benzoyl Peroxide

By Acne Type

  • Non-inflammatory acne
  • Inflammatory acne

By Formulation

  • Topical Medication
  • Oral Medication

By Distribution Channel

  • Retail Store
  • Pharmacy and Drug Store
  • E-Commerce

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
Key Market Players
  • AbbVie Inc.
  • Botanix Pharmaceuticals
  • Galderma S.A.
  • Bausch Health Companies Inc
  • GlaxoSmithKline Plc.
  • Bayer AG
  • Kenvue Inc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mayne Pharma Group Limited.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
4.1. Overview
4.1.1. Market size and forecast
4.2. Retinoid
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Retinoid Acne Medication Market by Type
4.3. Antibiotic
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Antibiotic Acne Medication Market by Type
4.4. Salicylic Acid
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Benzoyl Peroxide
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Other medications
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: ACNE MEDICATION MARKET, BY FORMULATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Topical Medication
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Oral Medication
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: ACNE MEDICATION MARKET, BY TYPE
6.1. Overview
6.1.1. Market size and forecast
6.2. Prescription Medicine
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Over-the-counter medicines
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: ACNE MEDICATION MARKET, BY ACNE TYPE
7.1. Overview
7.1.1. Market size and forecast
7.2. Non-inflammatory acne
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Inflammatory acne
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
CHAPTER 8: ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
8.1. Overview
8.1.1. Market size and forecast
8.2. Retail Store
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by region
8.2.3. Market share analysis by country
8.3. Pharmacy and Drug Store
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by region
8.3.3. Market share analysis by country
8.4. E-Commerce
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by region
8.4.3. Market share analysis by country
CHAPTER 9: ACNE MEDICATION MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast By Region
9.2. North America
9.2.1. Key market trends, growth factors and opportunities
9.2.2. Market size and forecast, by Therapeutic Class
9.2.3. Market size and forecast, by Formulation
9.2.4. Market size and forecast, by Type
9.2.5. Market size and forecast, by Acne Type
9.2.6. Market size and forecast, by Distribution Channel
9.2.7. Market size and forecast, by country
9.2.7.1. U.S.
9.2.7.1.1. Market size and forecast, by Therapeutic Class
9.2.7.1.2. Market size and forecast, by Formulation
9.2.7.1.3. Market size and forecast, by Type
9.2.7.1.4. Market size and forecast, by Acne Type
9.2.7.1.5. Market size and forecast, by Distribution Channel
9.2.7.2. Canada
9.2.7.2.1. Market size and forecast, by Therapeutic Class
9.2.7.2.2. Market size and forecast, by Formulation
9.2.7.2.3. Market size and forecast, by Type
9.2.7.2.4. Market size and forecast, by Acne Type
9.2.7.2.5. Market size and forecast, by Distribution Channel
9.2.7.3. Mexico
9.2.7.3.1. Market size and forecast, by Therapeutic Class
9.2.7.3.2. Market size and forecast, by Formulation
9.2.7.3.3. Market size and forecast, by Type
9.2.7.3.4. Market size and forecast, by Acne Type
9.2.7.3.5. Market size and forecast, by Distribution Channel
9.3. Europe
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Market size and forecast, by Therapeutic Class
9.3.3. Market size and forecast, by Formulation
9.3.4. Market size and forecast, by Type
9.3.5. Market size and forecast, by Acne Type
9.3.6. Market size and forecast, by Distribution Channel
9.3.7. Market size and forecast, by country
9.3.7.1. Germany
9.3.7.1.1. Market size and forecast, by Therapeutic Class
9.3.7.1.2. Market size and forecast, by Formulation
9.3.7.1.3. Market size and forecast, by Type
9.3.7.1.4. Market size and forecast, by Acne Type
9.3.7.1.5. Market size and forecast, by Distribution Channel
9.3.7.2. France
9.3.7.2.1. Market size and forecast, by Therapeutic Class
9.3.7.2.2. Market size and forecast, by Formulation
9.3.7.2.3. Market size and forecast, by Type
9.3.7.2.4. Market size and forecast, by Acne Type
9.3.7.2.5. Market size and forecast, by Distribution Channel
9.3.7.3. UK
9.3.7.3.1. Market size and forecast, by Therapeutic Class
9.3.7.3.2. Market size and forecast, by Formulation
9.3.7.3.3. Market size and forecast, by Type
9.3.7.3.4. Market size and forecast, by Acne Type
9.3.7.3.5. Market size and forecast, by Distribution Channel
9.3.7.4. Italy
9.3.7.4.1. Market size and forecast, by Therapeutic Class
9.3.7.4.2. Market size and forecast, by Formulation
9.3.7.4.3. Market size and forecast, by Type
9.3.7.4.4. Market size and forecast, by Acne Type
9.3.7.4.5. Market size and forecast, by Distribution Channel
9.3.7.5. Spain
9.3.7.5.1. Market size and forecast, by Therapeutic Class
9.3.7.5.2. Market size and forecast, by Formulation
9.3.7.5.3. Market size and forecast, by Type
9.3.7.5.4. Market size and forecast, by Acne Type
9.3.7.5.5. Market size and forecast, by Distribution Channel
9.3.7.6. Rest of Europe
9.3.7.6.1. Market size and forecast, by Therapeutic Class
9.3.7.6.2. Market size and forecast, by Formulation
9.3.7.6.3. Market size and forecast, by Type
9.3.7.6.4. Market size and forecast, by Acne Type
9.3.7.6.5. Market size and forecast, by Distribution Channel
9.4. Asia-Pacific
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Market size and forecast, by Therapeutic Class
9.4.3. Market size and forecast, by Formulation
9.4.4. Market size and forecast, by Type
9.4.5. Market size and forecast, by Acne Type
9.4.6. Market size and forecast, by Distribution Channel
9.4.7. Market size and forecast, by country
9.4.7.1. Japan
9.4.7.1.1. Market size and forecast, by Therapeutic Class
9.4.7.1.2. Market size and forecast, by Formulation
9.4.7.1.3. Market size and forecast, by Type
9.4.7.1.4. Market size and forecast, by Acne Type
9.4.7.1.5. Market size and forecast, by Distribution Channel
9.4.7.2. China
9.4.7.2.1. Market size and forecast, by Therapeutic Class
9.4.7.2.2. Market size and forecast, by Formulation
9.4.7.2.3. Market size and forecast, by Type
9.4.7.2.4. Market size and forecast, by Acne Type
9.4.7.2.5. Market size and forecast, by Distribution Channel
9.4.7.3. Australia
9.4.7.3.1. Market size and forecast, by Therapeutic Class
9.4.7.3.2. Market size and forecast, by Formulation
9.4.7.3.3. Market size and forecast, by Type
9.4.7.3.4. Market size and forecast, by Acne Type
9.4.7.3.5. Market size and forecast, by Distribution Channel
9.4.7.4. India
9.4.7.4.1. Market size and forecast, by Therapeutic Class
9.4.7.4.2. Market size and forecast, by Formulation
9.4.7.4.3. Market size and forecast, by Type
9.4.7.4.4. Market size and forecast, by Acne Type
9.4.7.4.5. Market size and forecast, by Distribution Channel
9.4.7.5. South Korea
9.4.7.5.1. Market size and forecast, by Therapeutic Class
9.4.7.5.2. Market size and forecast, by Formulation
9.4.7.5.3. Market size and forecast, by Type
9.4.7.5.4. Market size and forecast, by Acne Type
9.4.7.5.5. Market size and forecast, by Distribution Channel
9.4.7.6. Rest of Asia-Pacific
9.4.7.6.1. Market size and forecast, by Therapeutic Class
9.4.7.6.2. Market size and forecast, by Formulation
9.4.7.6.3. Market size and forecast, by Type
9.4.7.6.4. Market size and forecast, by Acne Type
9.4.7.6.5. Market size and forecast, by Distribution Channel
9.5. LAMEA
9.5.1. Key market trends, growth factors and opportunities
9.5.2. Market size and forecast, by Therapeutic Class
9.5.3. Market size and forecast, by Formulation
9.5.4. Market size and forecast, by Type
9.5.5. Market size and forecast, by Acne Type
9.5.6. Market size and forecast, by Distribution Channel
9.5.7. Market size and forecast, by country
9.5.7.1. Brazil
9.5.7.1.1. Market size and forecast, by Therapeutic Class
9.5.7.1.2. Market size and forecast, by Formulation
9.5.7.1.3. Market size and forecast, by Type
9.5.7.1.4. Market size and forecast, by Acne Type
9.5.7.1.5. Market size and forecast, by Distribution Channel
9.5.7.2. Saudi Arabia
9.5.7.2.1. Market size and forecast, by Therapeutic Class
9.5.7.2.2. Market size and forecast, by Formulation
9.5.7.2.3. Market size and forecast, by Type
9.5.7.2.4. Market size and forecast, by Acne Type
9.5.7.2.5. Market size and forecast, by Distribution Channel
9.5.7.3. South Africa
9.5.7.3.1. Market size and forecast, by Therapeutic Class
9.5.7.3.2. Market size and forecast, by Formulation
9.5.7.3.3. Market size and forecast, by Type
9.5.7.3.4. Market size and forecast, by Acne Type
9.5.7.3.5. Market size and forecast, by Distribution Channel
9.5.7.4. Rest of LAMEA
9.5.7.4.1. Market size and forecast, by Therapeutic Class
9.5.7.4.2. Market size and forecast, by Formulation
9.5.7.4.3. Market size and forecast, by Type
9.5.7.4.4. Market size and forecast, by Acne Type
9.5.7.4.5. Market size and forecast, by Distribution Channel
CHAPTER 10: COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Top winning strategies
10.3. Product mapping of top 10 player
10.4. Competitive dashboard
10.5. Competitive heatmap
10.6. Top player positioning, 2023
CHAPTER 11: COMPANY PROFILES
11.1. AbbVie Inc.
11.1.1. Company overview
11.1.2. Key executives
11.1.3. Company snapshot
11.1.4. Operating business segments
11.1.5. Product portfolio
11.1.6. Business performance
11.1.7. Key strategic moves and developments
11.2. Botanix Pharmaceuticals
11.2.1. Company overview
11.2.2. Key executives
11.2.3. Company snapshot
11.2.4. Operating business segments
11.2.5. Product portfolio
11.2.6. Business performance
11.2.7. Key strategic moves and developments
11.3. Galderma S.A.
11.3.1. Company overview
11.3.2. Key executives
11.3.3. Company snapshot
11.3.4. Operating business segments
11.3.5. Product portfolio
11.3.6. Business performance
11.3.7. Key strategic moves and developments
11.4. Bausch Health Companies Inc
11.4.1. Company overview
11.4.2. Key executives
11.4.3. Company snapshot
11.4.4. Operating business segments
11.4.5. Product portfolio
11.4.6. Business performance
11.4.7. Key strategic moves and developments
11.5. GlaxoSmithKline Plc.
11.5.1. Company overview
11.5.2. Key executives
11.5.3. Company snapshot
11.5.4. Operating business segments
11.5.5. Product portfolio
11.5.6. Business performance
11.5.7. Key strategic moves and developments
11.6. Bayer AG
11.6.1. Company overview
11.6.2. Key executives
11.6.3. Company snapshot
11.6.4. Operating business segments
11.6.5. Product portfolio
11.6.6. Business performance
11.6.7. Key strategic moves and developments
11.7. Kenvue Inc
11.7.1. Company overview
11.7.2. Key executives
11.7.3. Company snapshot
11.7.4. Operating business segments
11.7.5. Product portfolio
11.7.6. Business performance
11.7.7. Key strategic moves and developments
11.8. Pfizer Inc.
11.8.1. Company overview
11.8.2. Key executives
11.8.3. Company snapshot
11.8.4. Operating business segments
11.8.5. Product portfolio
11.8.6. Business performance
11.8.7. Key strategic moves and developments
11.9. Teva Pharmaceutical Industries Ltd.
11.9.1. Company overview
11.9.2. Key executives
11.9.3. Company snapshot
11.9.4. Operating business segments
11.9.5. Product portfolio
11.9.6. Business performance
11.9.7. Key strategic moves and developments
11.10. Mayne Pharma Group Limited.
11.10.1. Company overview
11.10.2. Key executives
11.10.3. Company snapshot
11.10.4. Operating business segments
11.10.5. Product portfolio
11.10.6. Business performance
11.10.7. Key strategic moves and developments
List of Tables
Table 01. Global Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 02. Acne Medication Market for Retinoid, by Region, 2023-2035 ($Million)
Table 03. Global Retinoid Acne Medication Market, by Type, 2023-2035 ($Million)
Table 04. Acne Medication Market for Antibiotic, by Region, 2023-2035 ($Million)
Table 05. Global Antibiotic Acne Medication Market, by Type, 2023-2035 ($Million)
Table 06. Acne Medication Market for Salicylic Acid, by Region, 2023-2035 ($Million)
Table 07. Acne Medication Market for Benzoyl Peroxide, by Region, 2023-2035 ($Million)
Table 08. Acne Medication Market for Other Medications, by Region, 2023-2035 ($Million)
Table 09. Global Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 10. Acne Medication Market for Topical Medication, by Region, 2023-2035 ($Million)
Table 11. Acne Medication Market for Oral Medication, by Region, 2023-2035 ($Million)
Table 12. Global Acne Medication Market, by Type, 2023-2035 ($Million)
Table 13. Acne Medication Market for Prescription Medicine, by Region, 2023-2035 ($Million)
Table 14. Acne Medication Market for Over-The-Counter Medicines, by Region, 2023-2035 ($Million)
Table 15. Global Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 16. Acne Medication Market for Non-Inflammatory Acne, by Region, 2023-2035 ($Million)
Table 17. Acne Medication Market for Inflammatory Acne, by Region, 2023-2035 ($Million)
Table 18. Global Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 19. Acne Medication Market for Retail Store, by Region, 2023-2035 ($Million)
Table 20. Acne Medication Market for Pharmacy and Drug Store, by Region, 2023-2035 ($Million)
Table 21. Acne Medication Market for E-Commerce, by Region, 2023-2035 ($Million)
Table 22. Acne Medication Market, by Region, 2023-2035 ($Million)
Table 23. North America Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 24. North America Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 25. North America Acne Medication Market, by Type, 2023-2035 ($Million)
Table 26. North America Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 27. North America Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 28. North America Acne Medication Market, by Country, 2023-2035 ($Million)
Table 29. U.S. Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 30. U.S. Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 31. U.S. Acne Medication Market, by Type, 2023-2035 ($Million)
Table 32. U.S. Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 33. U.S. Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 34. Canada Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 35. Canada Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 36. Canada Acne Medication Market, by Type, 2023-2035 ($Million)
Table 37. Canada Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 38. Canada Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 39. Mexico Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 40. Mexico Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 41. Mexico Acne Medication Market, by Type, 2023-2035 ($Million)
Table 42. Mexico Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 43. Mexico Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 44. Europe Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 45. Europe Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 46. Europe Acne Medication Market, by Type, 2023-2035 ($Million)
Table 47. Europe Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 48. Europe Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 49. Europe Acne Medication Market, by Country, 2023-2035 ($Million)
Table 50. Germany Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 51. Germany Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 52. Germany Acne Medication Market, by Type, 2023-2035 ($Million)
Table 53. Germany Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 54. Germany Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 55. France Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 56. France Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 57. France Acne Medication Market, by Type, 2023-2035 ($Million)
Table 58. France Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 59. France Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 60. UK Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 61. UK Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 62. UK Acne Medication Market, by Type, 2023-2035 ($Million)
Table 63. UK Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 64. UK Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 65. Italy Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 66. Italy Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 67. Italy Acne Medication Market, by Type, 2023-2035 ($Million)
Table 68. Italy Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 69. Italy Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 70. Spain Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 71. Spain Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 72. Spain Acne Medication Market, by Type, 2023-2035 ($Million)
Table 73. Spain Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 74. Spain Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 75. Rest of Europe Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 76. Rest of Europe Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 77. Rest of Europe Acne Medication Market, by Type, 2023-2035 ($Million)
Table 78. Rest of Europe Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 79. Rest of Europe Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 80. Asia-Pacific Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 81. Asia-Pacific Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 82. Asia-Pacific Acne Medication Market, by Type, 2023-2035 ($Million)
Table 83. Asia-Pacific Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 84. Asia-Pacific Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 85. Asia-Pacific Acne Medication Market, by Country, 2023-2035 ($Million)
Table 86. Japan Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 87. Japan Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 88. Japan Acne Medication Market, by Type, 2023-2035 ($Million)
Table 89. Japan Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 90. Japan Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 91. China Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 92. China Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 93. China Acne Medication Market, by Type, 2023-2035 ($Million)
Table 94. China Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 95. China Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 96. Australia Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 97. Australia Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 98. Australia Acne Medication Market, by Type, 2023-2035 ($Million)
Table 99. Australia Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 100. Australia Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 101. India Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 102. India Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 103. India Acne Medication Market, by Type, 2023-2035 ($Million)
Table 104. India Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 105. India Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 106. South Korea Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 107. South Korea Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 108. South Korea Acne Medication Market, by Type, 2023-2035 ($Million)
Table 109. South Korea Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 110. South Korea Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 111. Rest of Asia-Pacific Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 112. Rest of Asia-Pacific Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 113. Rest of Asia-Pacific Acne Medication Market, by Type, 2023-2035 ($Million)
Table 114. Rest of Asia-Pacific Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 115. Rest of Asia-Pacific Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 116. LAMEA Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 117. LAMEA Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 118. LAMEA Acne Medication Market, by Type, 2023-2035 ($Million)
Table 119. LAMEA Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 120. LAMEA Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 121. LAMEA Acne Medication Market, by Country, 2023-2035 ($Million)
Table 122. Brazil Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 123. Brazil Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 124. Brazil Acne Medication Market, by Type, 2023-2035 ($Million)
Table 125. Brazil Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 126. Brazil Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 127. Saudi Arabia Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 128. Saudi Arabia Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 129. Saudi Arabia Acne Medication Market, by Type, 2023-2035 ($Million)
Table 130. Saudi Arabia Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 131. Saudi Arabia Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 132. South Africa Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 133. South Africa Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 134. South Africa Acne Medication Market, by Type, 2023-2035 ($Million)
Table 135. South Africa Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 136. South Africa Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 137. Rest of LAMEA Acne Medication Market, by Therapeutic Class, 2023-2035 ($Million)
Table 138. Rest of LAMEA Acne Medication Market, by Formulation, 2023-2035 ($Million)
Table 139. Rest of LAMEA Acne Medication Market, by Type, 2023-2035 ($Million)
Table 140. Rest of LAMEA Acne Medication Market, by Acne Type, 2023-2035 ($Million)
Table 141. Rest of LAMEA Acne Medication Market, by Distribution Channel, 2023-2035 ($Million)
Table 142. Abbvie Inc.: Key Executives
Table 143. Abbvie Inc.: Company Snapshot
Table 144. Abbvie Inc.: Product Segments
Table 145. Abbvie Inc.: Service Segments
Table 146. Abbvie Inc.: Product Portfolio
Table 147. Abbvie Inc.: Key Strategies
Table 148. Botanix Pharmaceuticals: Key Executives
Table 149. Botanix Pharmaceuticals: Company Snapshot
Table 150. Botanix Pharmaceuticals: Product Segments
Table 151. Botanix Pharmaceuticals: Service Segments
Table 152. Botanix Pharmaceuticals: Product Portfolio
Table 153. Botanix Pharmaceuticals: Key Strategies
Table 154. Galderma SA: Key Executives
Table 155. Galderma SA: Company Snapshot
Table 156. Galderma SA: Product Segments
Table 157. Galderma SA: Service Segments
Table 158. Galderma SA: Product Portfolio
Table 159. Galderma SA: Key Strategies
Table 160. Bausch Health Companies Inc.: Key Executives
Table 161. Bausch Health Companies Inc.: Company Snapshot
Table 162. Bausch Health Companies Inc.: Product Segments
Table 163. Bausch Health Companies Inc.: Service Segments
Table 164. Bausch Health Companies Inc.: Product Portfolio
Table 165. Bausch Health Companies Inc.: Key Strategies
Table 166. GlaxoSmithKline PLC.: Key Executives
Table 167. GlaxoSmithKline PLC.: Company Snapshot
Table 168. GlaxoSmithKline PLC.: Product Segments
Table 169. GlaxoSmithKline PLC.: Service Segments
Table 170. GlaxoSmithKline PLC.: Product Portfolio
Table 171. GlaxoSmithKline PLC.: Key Strategies
Table 172. Bayer AG: Key Executives
Table 173. Bayer AG: Company Snapshot
Table 174. Bayer AG: Product Segments
Table 175. Bayer AG: Service Segments
Table 176. Bayer AG: Product Portfolio
Table 177. Bayer AG: Key Strategies
Table 178. Kenvue Inc.: Key Executives
Table 179. Kenvue Inc.: Company Snapshot
Table 180. Kenvue Inc.: Product Segments
Table 181. Kenvue Inc.: Service Segments
Table 182. Kenvue Inc.: Product Portfolio
Table 183. Kenvue Inc.: Key Strategies
Table 184. Pfizer Inc.: Key Executives
Table 185. Pfizer Inc.: Company Snapshot
Table 186. Pfizer Inc.: Product Segments
Table 187. Pfizer Inc.: Service Segments
Table 188. Pfizer Inc.: Product Portfolio
Table 189. Pfizer Inc.: Key Strategies
Table 190. Teva Pharmaceutical Industries Ltd.: Key Executives
Table 191. Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 192. Teva Pharmaceutical Industries Ltd.: Product Segments
Table 193. Teva Pharmaceutical Industries Ltd.: Service Segments
Table 194. Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 195. Teva Pharmaceutical Industries Ltd.: Key Strategies
Table 196. Mayne Pharma Group Limited.: Key Executives
Table 197. Mayne Pharma Group Limited.: Company Snapshot
Table 198. Mayne Pharma Group Limited.: Product Segments
Table 199. Mayne Pharma Group Limited.: Service Segments
Table 200. Mayne Pharma Group Limited.: Product Portfolio
Table 201. Mayne Pharma Group Limited.: Key Strategies
List of Figures
Figure 01. Acne Medication Market, 2023-2035
Figure 02. Segmentation of Acne Medication Market,2023-2035
Figure 03. Top Impacting Factors in Acne Medication Market
Figure 04. Top Investment Pockets in Acne Medication Market (2024-2035)
Figure 05. Bargaining Power of Suppliers
Figure 06. Bargaining Power of Buyers
Figure 07. Threat of Substitution
Figure 08. Threat of Substitution
Figure 09. Competitive Rivalry
Figure 10. Global Acne Medication Market:Drivers, Restraints and Opportunities
Figure 11. Acne Medication Market, by Therapeutic Class, 2023 and 2035(%)
Figure 12. Comparative Share Analysis of Acne Medication Market for Retinoid, by Country 2023 and 2035(%)
Figure 13. Comparative Share Analysis of Acne Medication Market for Antibiotic, by Country 2023 and 2035(%)
Figure 14. Comparative Share Analysis of Acne Medication Market for Salicylic Acid, by Country 2023 and 2035(%)
Figure 15. Comparative Share Analysis of Acne Medication Market for Benzoyl Peroxide, by Country 2023 and 2035(%)
Figure 16. Comparative Share Analysis of Acne Medication Market for Other Medications, by Country 2023 and 2035(%)
Figure 17. Acne Medication Market, by Formulation, 2023 and 2035(%)
Figure 18. Comparative Share Analysis of Acne Medication Market for Topical Medication, by Country 2023 and 2035(%)
Figure 19. Comparative Share Analysis of Acne Medication Market for Oral Medication, by Country 2023 and 2035(%)
Figure 20. Acne Medication Market, by Type, 2023 and 2035(%)
Figure 21. Comparative Share Analysis of Acne Medication Market for Prescription Medicine, by Country 2023 and 2035(%)
Figure 22. Comparative Share Analysis of Acne Medication Market for Over-The-Counter Medicines, by Country 2023 and 2035(%)
Figure 23. Acne Medication Market, by Acne Type, 2023 and 2035(%)
Figure 24. Comparative Share Analysis of Acne Medication Market for Non-Inflammatory Acne, by Country 2023 and 2035(%)
Figure 25. Comparative Share Analysis of Acne Medication Market for Inflammatory Acne, by Country 2023 and 2035(%)
Figure 26. Acne Medication Market, by Distribution Channel, 2023 and 2035(%)
Figure 27. Comparative Share Analysis of Acne Medication Market for Retail Store, by Country 2023 and 2035(%)
Figure 28. Comparative Share Analysis of Acne Medication Market for Pharmacy and Drug Store, by Country 2023 and 2035(%)
Figure 29. Comparative Share Analysis of Acne Medication Market for E-Commerce, by Country 2023 and 2035(%)
Figure 30. Acne Medication Market by Region, 2023 and 2035(%)
Figure 31. U.S. Acne Medication Market, 2023-2035 ($Million)
Figure 32. Canada Acne Medication Market, 2023-2035 ($Million)
Figure 33. Mexico Acne Medication Market, 2023-2035 ($Million)
Figure 34. Germany Acne Medication Market, 2023-2035 ($Million)
Figure 35. France Acne Medication Market, 2023-2035 ($Million)
Figure 36. UK Acne Medication Market, 2023-2035 ($Million)
Figure 37. Italy Acne Medication Market, 2023-2035 ($Million)
Figure 38. Spain Acne Medication Market, 2023-2035 ($Million)
Figure 39. Rest of Europe Acne Medication Market, 2023-2035 ($Million)
Figure 40. Japan Acne Medication Market, 2023-2035 ($Million)
Figure 41. China Acne Medication Market, 2023-2035 ($Million)
Figure 42. Australia Acne Medication Market, 2023-2035 ($Million)
Figure 43. India Acne Medication Market, 2023-2035 ($Million)
Figure 44. South Korea Acne Medication Market, 2023-2035 ($Million)
Figure 45. Rest of Asia-Pacific Acne Medication Market, 2023-2035 ($Million)
Figure 46. Brazil Acne Medication Market, 2023-2035 ($Million)
Figure 47. Saudi Arabia Acne Medication Market, 2023-2035 ($Million)
Figure 48. South Africa Acne Medication Market, 2023-2035 ($Million)
Figure 49. Rest of LAMEA Acne Medication Market, 2023-2035 ($Million)
Figure 50. Top Winning Strategies, by Year
Figure 51. Top Winning Strategies, by Development
Figure 52. Top Winning Strategies, by Company
Figure 53. Product Mapping of Top 10 Players
Figure 54. Competitive Dashboard
Figure 55. Competitive Heatmap: Acne Medication Market
Figure 56. Top Player Positioning, 2023

Companies Mentioned

Key Market Players in the Acne Medication Market include:
  • AbbVie Inc.
  • Botanix Pharmaceuticals
  • Galderma S.A.
  • Bausch Health Companies Inc
  • GlaxoSmithKline Plc.
  • Bayer AG
  • Kenvue Inc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mayne Pharma Group Limited.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages280
PublishedApril 2024
Forecast Period2023 - 2035
Estimated Market Value ( USD ) in 2023 $ 13.4 billion
Forecasted Market Value ( USD ) by 2035 $ 24.2 billion
Compound Annual Growth Rate5.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Asia Pacific Acne Medication Market Forecast to 2030 - Regional Analysis by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel - Product Image

Asia Pacific Acne Medication Market Forecast to 2030 - Regional Analysis by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

  • Report
  • 128 Pages
  • Asia Pacific
From
Europe Acne Medication Market Forecast to 2030 - Regional Analysis by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel - Product Image

Europe Acne Medication Market Forecast to 2030 - Regional Analysis by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

  • Report
  • 127 Pages
  • Europe
From
Acne Medication Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Class, Formulation, Type, Acne Type, Distribution Channel, and Geography - Product Image

Acne Medication Market Size and Forecast 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Class, Formulation, Type, Acne Type, Distribution Channel, and Geography

  • Report
  • 229 Pages
  • Global
From
South & Central America Acne Medication Market Forecast to 2030 - Regional Analysis by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel - Product Image

South & Central America Acne Medication Market Forecast to 2030 - Regional Analysis by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

  • Report
  • 111 Pages
From
North America Acne Medication Market Forecast to 2030 - Regional Analysis by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel - Product Image

North America Acne Medication Market Forecast to 2030 - Regional Analysis by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

  • Report
  • 121 Pages
  • North America
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.